Biofidelity in the News
Biofidelity raises further $23m as it moves towards launch of ASPYRE-Lung diagnostic product
10 February 2022
10 February 2022
Morrisville firm with 'game-changing' cancer diagnostics plots growth after $23M haul
07 February 2022
07 February 2022
02 February 2022
05 November 2021
New California Law Increases Access to Biomarker Testing for Late-Stage Cancer Patients
25 October 2021
25 October 2021
California Bill Prohibiting Prior Authorizations for Cancer Biomarker Testing Becomes Law
13 October 2021
13 October 2021
Breaking Down Barriers: Improving Access to Comprehensive Biomarker Testing for Cancer Patients
24 September 2021
24 September 2021